CW July 2005Issue Number 7 July 2005 ISSN 10593802 Avastin Plus Paclitaxel and Carboplatin Improves Non-Small Cell Lung Cancer SurvivalFor the first time, a study has shown that adding a targeted therapy to standard chemotherapy can improve survival of non-small cell lung cancer patients.
Go to Previous Page Go to Next Page Source & Additional Reading A. B. Sandler, 41st Annual Meeting of the American Society of Clinical Oncology. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW July 2005Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |